Where are we now with CBD and other questions facing dermatology? Perspectives from Adam Friedman, MD episode artwork

EPISODE · Jul 8, 2021 · 22 MIN

Where are we now with CBD and other questions facing dermatology? Perspectives from Adam Friedman, MD

from Derms and Conditions · host Dermsquared

In Episode 7 of Derms and Conditions, our host James Del Rosso, DO talks with Adam Friedman, MD, Professor and Chair of Dermatology at The George Washington University School of Medicine & Health Sciences on the use of topical CBD in dermatology and the use of oral spironolactone in breast cancer patients.  Dr. Del Rosso and Dr. Friedman discuss many diverse topics on CBD including FDA regulations, counseling patients, and clinical studies on topical CBD gel in the treatment of xerosis and atopic dermatitis. They further discuss evidence regarding the risk of oral spironolactone in breast cancer recurrence along with effective ways to manage and counsel patients who have a personal or family history of breast cancer.

Episode metadata supplied by the publisher feed · Published Jul 8, 2021

Embed this episode

Ready to play

Where are we now with CBD and other questions facing dermatology? Perspectives from Adam Friedman, MD

0:00 22:47

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Derms and Conditions?

This episode is 22 minutes long.

When was this Derms and Conditions episode published?

This episode was published on July 8, 2021.

Can I download this Derms and Conditions episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!